Home » Topics » BioWorld Science

BioWorld Science
RSS

Glaxo Wellcome claims 5alpha-reductase inhibitors for BPH

Nov. 19, 1996

Novo Nordisk claims immunosuppressive serine palmitoyl transferase inhibitors

Nov. 19, 1996

Second NDA submitted for Crinone

Nov. 15, 1996

Lilly reports agents to treat menopause-related conditions

Nov. 15, 1996

Vasomax enters pivotal trials

Nov. 15, 1996

PKC inhibitors from Lilly for various therapeutic indications

Nov. 15, 1996

Wyeth-Ayerst withdraws diabetes drug from markets worldwide

Nov. 15, 1996

Imidazoline compound reported as lead for oral hypoglycemic agents

Nov. 15, 1996

Takeda describes potential antidiabetic agents

Nov. 15, 1996

Hyperparathyroidism Rx from NPS effective in dialysis patients

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...